Chemotherapy-related cognitive impairment: does integrating complementary medicine have something to add? Review of the literature (Q38036929)

27 August 2017

Chemotherapy-related cognitive impairment: does integrating complementary medicine have something to add? Review of the literature (English)

1 reference

27 August 2017

1 reference

cognitive dysfunction

1 reference

Adva Avisar

1

1 reference

27 August 2017

Yaron River

2

1 reference

27 August 2017

Elad Schiff

3

1 reference

27 August 2017

Gil Bar-Sela

4

1 reference

27 August 2017

Mariana Steiner

5

1 reference

27 August 2017

Eran Ben-Arye

6

1 reference

27 August 2017

language of work or name

English

0 references

publication date

23 August 2012

1 reference

Breast Cancer Research and Treatment

27 August 2017

1 reference

27 August 2017

136

1 reference

27 August 2017

1

1 reference

27 August 2017

1-7

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-012-2211-5

27 August 2017

0 references

cites work

Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients--evaluation of appropriate research design and methodology to measure symptoms

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Neuropsychological studies in breast cancer: in search of chemobrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Candidate mechanisms for chemotherapy-induced cognitive changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Intrathecal methotrexate induces focal cognitive deficits and increases cerebrospinal fluid homocysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Cognitive assessment of children with acute lymphoblastic leukemia: Preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Intrathecal methotrexate affects cognitive function in children with medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Capecitabine-induced cerebellar toxicity in a patient with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Chemobrain: imaging shows changes in metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

'Chemobrain' in breast carcinoma?: a prologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

21 January 2018

Renaming "chemobrain"

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Mild cognitive impairment: conceptual issues and structural and functional brain correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

The effect of modafinil on cognitive function in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Cognitive-behavioral management of chemotherapy-related cognitive change

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Patients' experiences with cognitive changes after chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Acupuncture for chemotherapy-associated cognitive dysfunction: a hypothesis-generating literature review to inform clinical advice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Scalp acupuncture effect on language development in children with autism: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Acupuncture prevents cognitive deficits and oxidative stress in cerebral multi-infarction rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Acupuncture improved cognitive impairment caused by multi-infarct dementia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Acupuncture improves cognitive deficits and regulates the brain cell proliferation of SAMP8 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Use of alternative therapies in patients with dementia and mild cognitive impairment: a prospective, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

A randomized, double-blind, placebo-controlled clinical trial of the Chinese herbal medicine "ba wei di huang wan" in the treatment of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Current therapies in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

An examination of the effects of the antioxidant Pycnogenol on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Herb-drug interactions: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Herbal medication: potential for adverse interactions with analgesic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Ginkgo biloba did not prevent dementia or Alzheimer disease in elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Ginkgo biloba for prevention of dementia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Cancer, cognitive impairment, and meditation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Does meditation enhance cognition and brain plasticity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Age effects on gray matter volume and attentional performance in Zen meditation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Mindfulness meditation training in adults and adolescents with ADHD: a feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Flexyx Neurotherapy System in the treatment of traumatic brain injury: an initial evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Evaluation of haptotherapy for patients with cancer treated with chemotherapy at a day clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Complementary and alternative medicine in the treatment of anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

A primer of complementary and alternative medicine and its relevance in the treatment of mental health problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Anxiety, depression and acupuncture: A review of the clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

HYPNOSIS TO MANAGE DISTRESS RELATED TO MEDICAL PROCEDURES: A META-ANALYSIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Hypnosis reduces distress and duration of an invasive medical procedure for children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Hypnosis decreases presurgical distress in excisional breast biopsy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Suggestion, relaxation, and hypnosis as adjuncts in the care of surgery patients: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Specificity of treatment effects: cognitive therapy and relaxation for generalized anxiety and panic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Can relaxation training reduce emotional eating in women with obesity? An exploratory study with 3 months of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Relaxation versus cognitive therapies for dental fear--a psychophysiological approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Effects of herbal products on the metabolism and transport of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

A systematic review of the safety of kava extract in the treatment of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Complementary and alternative medicine (CAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Patterns of complementary and alternative medicine use among patients undergoing cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Complementary and alternative medicine use among US adults with common neurological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

Complementary and alternative medicine use by otolaryngology patients: a paradigm for practitioners in all surgical specialties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

'They don't ask me so I don't tell them': patient-clinician communication about traditional, complementary, and alternative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2211-5

10.1007/S10549-012-2211-5

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference